These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38939068)

  • 21. Evaluation of Proton Pump Inhibitors Prescribing Among Hospitalized Patients: A Cross-Sectional Study.
    Abukhalil AD; Ali O; Saad A; Falana H; Al-Shami N; Naseef HA; Rabba A
    Int J Gen Med; 2023; 16():141-150. PubMed ID: 36659914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?
    Ben-Eltriki M; Chhabra M; Cassels A; Wright JM
    Curr Drug Saf; 2024; 19(2):244-247. PubMed ID: 37496243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of proton pump inhibitors in children: a comprehensive review.
    Gibbons TE; Gold BD
    Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors.
    Rababa M; Rababa'h A
    BMC Geriatr; 2020 Oct; 20(1):431. PubMed ID: 33121444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitors for functional dyspepsia.
    Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.
    Scarpignato C; Gatta L; Zullo A; Blandizzi C; ;
    BMC Med; 2016 Nov; 14(1):179. PubMed ID: 27825371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship.
    Dutta AK; Jain A; Jearth V; Mahajan R; Panigrahi MK; Sharma V; Goenka MK; Kochhar R; Makharia G; Reddy DN; Kirubakaran R; Ahuja V; Berry N; Bhat N; Dutta U; Ghoshal UC; Jain A; Jalihal U; Jayanthi V; Kumar A; Nijhawan S; Poddar U; Ramesh GN; Singh SP; Zargar S; Bhatia S
    Indian J Gastroenterol; 2023 Oct; 42(5):601-628. PubMed ID: 37698821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of proton pump inhibitor management committee's multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments.
    Liu L; Yu Y; Fan Q; Wu Z; Li X; Luo H
    BMC Health Serv Res; 2022 Mar; 22(1):417. PubMed ID: 35351121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Awareness and Knowledge of Proton Pump Inhibitors Among the General Population in Saudi Arabia.
    Aljahdli ES; Mokhtar AM; Aljehani SA; Hamdi RM; Alsubhi BH; Aljuhani KF; Saleh KA; Alzoriri AD; Alghamdi WS
    Cureus; 2022 Jul; 14(7):e27149. PubMed ID: 36017269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irrational use of proton pump inhibitors in general practise.
    Ali O; Poole R; Okon M; Maunick S; Troy E
    Ir J Med Sci; 2019 May; 188(2):541-544. PubMed ID: 30136221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and Patterns of Proton Pump Inhibitors Prescribing at the Primary Health Care.
    Stojaković N; Golić Jelić A; Stoisavljević Šatara S; Bednarčuk N; Stojiljković MP; Škrbić R
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esomeprazole use is independently associated with significant reduction of BMD: 1-year prospective comparative safety study of four proton pump inhibitors.
    Bahtiri E; Islami H; Hoxha R; Qorraj-Bytyqi H; Rexhepi S; Hoti K; Thaçi K; Thaçi S; Karakulak Ç
    J Bone Miner Metab; 2016 Sep; 34(5):571-9. PubMed ID: 26209167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of nonformulary use of PPIs and excess drug cost in a Veterans Affairs population.
    Ajumobi AB; Vuong R; Ahaneku H
    J Manag Care Pharm; 2012; 18(1):63-7. PubMed ID: 22235956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors for functional dyspepsia.
    Pinto-Sanchez MI; Yuan Y; Bercik P; Moayyedi P
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011194. PubMed ID: 28271513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring of serum magnesium levels during long-term use of proton pump inhibitors in elderly japanese patients: is it really necessary or not?
    Nakamura N; Yoneda K; Higo T; Kusumoto M
    J Pharm Health Care Sci; 2022 Dec; 8(1):35. PubMed ID: 36514145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
    Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
    Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.